Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Editors :
Jennifer R. Brown︎ & Matthew S. Davids
This item will be released on 10-28-2025
In this issue of Hematology/Oncology Clinics, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of Chronic Lymphocytic Leukemia. Top experts provide in-depth perspectives on CLL, including basi ...view more
In this issue of Hematology/Oncology Clinics, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of Chronic Lymphocytic Leukemia. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction—offering a state-of-the-art overview of the field to help optimize the care of patients with CLL.
In this issue of Hematology/Oncology Clinics, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of Chronic Lymphocytic Leukemia. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction—offering a state-of-the-art overview of the field to help optimize the care of patients with CLL.
Key Features
Contains 13 relevant, practice-oriented topics including autonomous B cell receptor signaling; triple drug combinations; management of relapsed/refractory CLL; resistance to BTK inhibitors; immune therapy for CLL; and more
Provides in-depth clinical reviews on chronic lymphocytic leukemia, offering actionable insights for clinical practice
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Author Information
Edited by Jennifer R. Brown︎, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute, USA and Matthew S. Davids, MD, MMSc, Associate Professor of Medicine | Harvard Medical School Leader Lymphoma Program | Dana-Farber/Harvard Cancer Center Director of Clinical Research | Division of Lymphoma Dana-Farber Cancer Institute Boston, MA, USA
https://www.us.elsevierhealth.com/chronic-lymphocytic-leukemia-an-issue-of-hematologyoncology-clinics-of-north-america-9780443345470.html330316Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North Americahttps://www.us.elsevierhealth.com/media/catalog/product/https://www.us.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png108.99108.99USDInStockIn this issue of <i>Hematology/Oncology Clinics</i>, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of <b>Chronic Lymphocytic Leukemia</b>. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction—offering a state-of-the-art overview of the field to help optimize the care of patients with CLL. In this issue of <i>Hematology/Oncology Clinics</i>, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of <b>Chronic Lymphocytic Leukemia</b>. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction—offering a state-of-the-art overview of the field to help optimize the care of patients with CLL.00add-to-cart97804433454702025ProfessionalEdited by Jennifer R. Brown︎, MD, PhD and Matthew S. Davids, MD, MMSc20251Book152w x 229h (6.00" x 9.00")Elsevier240Oct 27, 2025NOT YET PUBLISHED Expected Release Date: 2025-10-28Edited by <STRONG>Jennifer R. Brown︎</STRONG>, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute, USA and <STRONG>Matthew S. Davids</STRONG>, MD, MMSc, Associate Professor of Medicine | Harvard Medical School Leader Lymphoma Program | Dana-Farber/Harvard Cancer Center Director of Clinical Research | Division of Lymphoma Dana-Farber Cancer Institute Boston, MA, USAClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
